Hims Stock Catapults 126% As Obesity-Drug Wars Rage On Amid FDA Scrutiny

Group 1 - Hims & Hers Health (HIMS) has established a cup-with-handle base, presenting a buy point at 60.55 [1] - The stock has experienced a significant surge of 126% year-to-date as of Monday [1] - Hims stock has been selected for IBD 50 Stocks To Watch, indicating strong market interest [1] Group 2 - The current market environment shows indexes near record highs as October begins [2]